Dispositivi per la somministrazione nasale Rapporto sulle dimensioni del mercato e sull'analisi delle quote | Previsioni 2031

  • Report Code : TIPRE00014905
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 215
Buy Now

Si prevede che il mercato dei dispositivi per la somministrazione nasale raggiungerà i 95.676,62 milioni di dollari entro il 2027 rispetto ai 58.502,18 milioni di dollari del 2019. Si stima che il mercato crescerà con un CAGR del 6,4% dal 2020 al 2027.

< p> 

La somministrazione di farmaci per via nasale è una delle vie di somministrazione dei farmaci preferite dai pazienti e dagli operatori sanitari. Ciò può essere attribuito principalmente alla natura non invasiva di questa via di somministrazione e alla maggiore assorbibilità del farmaco attraverso la via nasale. Inoltre, la via nasale offre un ambiente meno ostile per i farmaci rispetto alla via gastrointestinale, consentendo così un migliore assorbimento del farmaco. La facile somministrazione di questi farmaci svolge un ruolo cruciale nel migliorare la compliance alle terapie farmacologiche tra i pazienti, che a sua volta determina i risultati dei pazienti. Considerando questi fattori, la preferenza per la somministrazione di farmaci per via nasale è in aumento sia tra i pazienti che tra gli operatori sanitari. Essendo altamente vascolarizzata, la cavità nasale migliora l'assorbimento del farmaco con conseguente azione rapida. L’Organizzazione Mondiale della Sanità (OMS) dispone di linee guida specifiche per i produttori, che delineano tutti i requisiti necessari per l’adozione di nuovi dispositivi di somministrazione nasale con un sistema di somministrazione monouso. Pertanto, la somministrazione di farmaci per via nasale, a differenza di altre vie di somministrazione di farmaci, non richiede metodi sterili rigorosi per la somministrazione dei farmaci nell'organismo. Pertanto, l'elevata preferenza per la somministrazione di farmaci per via nasale da parte dei pazienti e degli operatori sanitari, dovuta alla crescente consapevolezza dei suoi benefici, sta guidando la crescita del mercato.

Mercati regionali redditizi per dispositivi di somministrazione nasale

Approfondimenti di mercato

Crescente prevalenza di malattie respiratorie e del sistema nervoso centrale

Gli studi iniziali di prova utilizzando Nuovi dispositivi per la somministrazione nasale di farmaci hanno mostrato risultati promettenti nel trattamento di malattie respiratorie, disturbi neurologici e altri. I dispositivi per la somministrazione di farmaci svolgono un ruolo essenziale nel garantire la somministrazione dell'intero farmaco al sito bersaglio nella cavità nasale. Negli ultimi decenni sono stati introdotti diversi approcci innovativi per la somministrazione di farmaci che potrebbero superare le sfide legate all’attraversamento della barriera ematoencefalica (BBB). Numerosi studi scientifici supportano l’ipotesi che la somministrazione di farmaci attraverso la via nasale possa consentire a concentrazioni più elevate di farmaci di attraversare la BEE. La crescente incidenza di disturbi neurologici aumenterebbe la domanda di dispositivi per la somministrazione nasale. Secondo l'American Society of Clinical Oncology (ASCO), nel 2020, negli Stati Uniti sono stati diagnosticati circa 3.540 tumori al cervello e ad altri tumori del sistema nervoso centrale in bambini appartenenti alla fascia di età compresa tra 0 e 14 anni. Il rapporto afferma inoltre che il cervello e altri tumori del sistema nervoso centrale sono i secondi tumori più comuni tra i bambini, rappresentando circa il 26% dei casi di cancro nei bambini di età

Il lancio e l'approvazione dei prodotti sono le strategie comunemente adottate dalle aziende per espandere la propria presenza globale e i portafogli di prodotti per soddisfare la crescente domanda dei consumatori. Gli operatori del mercato dei dispositivi per la somministrazione nasale adottano la strategia di collaborazioni per ampliare la base di clienti in tutto il mondo, il che consente loro anche di mantenere il proprio marchio a livello globale.

Mercato dei dispositivi per la somministrazione nasale: Per tipo di farmaco

  • Anestetici
  • Antibiotici
  • Farmaci antidolorifici
  • Integratori di calcio
  • Vasocostrittori< /li>
  • Antistaminici
  • Altri

 Mercato dei dispositivi per la somministrazione nasale - Per tecnologie di erogazione

  • Spray
  • Nebulizzatori
  • Inalatori
  • Altro

Nasale Mercato dei dispositivi di consegna - Per utente finale

  • Impostazioni di assistenza domiciliare
  • Ospedali
  • Cliniche

Mercato dei dispositivi per erogazione nasale - per area geografica

  • Nord America
    • Stati Uniti
    • Canada
    • Messico
  • < li>Europa
    • Francia
    • Germania
    • Italia
    • Regno Unito
    • Spagna
    • Resto dell'Europa
  • Asia Pacifico (APAC)
    • Cina
    • India
    • Corea del Sud
    • Giappone
    • Australia
    • Resto dell'Asia Pacifico
  • Medio Oriente e Asia Africa (MEA)
    • Sudafrica
    • Arabia Saudita
    • Emirati Arabi Uniti
    • Resto del Medio Oriente e dell'Africa. Africa
  • America Centrale e Meridionale
    • Brasile
    • Argentina
    • Resto del Sud America

Profili aziendali

  • GlaxoSmithKline plc.
  • AstraZeneca
  • Pfizer Inc
  • BD
  • Sanofi
  • Merck & Co., Inc.
  • Cadila Pharmaceuticals Ltd.
  • Novartis AG
  • Dr. Laboratori di Reddy
  • Neurelis, Inc
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are nasal delivery devices? What are the benefits?

Nasal drug delivery is one of the efficient route of drug administration. It offers needle-free drug delivery, optimal route for brain-targeted therapies, and superior bioavailability. Nasal route of administration is preferred in several disease indications such as Parkinson’s disease, prostate cancer, migraine, and influenza amongst others. Moreover, nasal route is also suitable for the treatment of drug addiction as well as for sedation.

What are the driving factors for the nasal delivery devices market across the globe?

The factors that are driving growth of the market are growing prevalence of respiratory and cns diseases and increasing preference and awareness of intranasal drug delivery among patients.Moreover, strategic activities by the manufacturersare offering lucrative opportunities for the growth of the market.

Who are the major players in the nasal delivery devices market?

The nasal delivery devices market majorly consists of the players such as GlaxoSmithKline plc.,AstraZeneca, Pfizer Inc., BD, Sanofi, Merck & Co., Inc., Cadila Pharmaceuticals Ltd., Novartis AG, Dr. Reddy's Laboratories, and Neurelis. amongst others.

The List of Companies - Nasal delivery devices Market

  1. GlaxoSmithKline plc.
  2. AstraZeneca
  3. Pfizer Inc.
  4. BD
  5. Sanofi
  6. Merck & Co., Inc.
  7. Cadila Pharmaceuticals Ltd.
  8. Novartis AG
  9. Dr. Reddy's Laboratories
  10. Neurelis, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports